Recently, Endo Pharmaceuticals has decided to stop the manufacturing of their needle-free migraine medication, Sumavel Dosepro. According to Endo Pharmaceuticals, the discontinuation of Sumavel DosePro was a business decision and not related to quality, safety, or efficacy concerns.
What is Sumavel DosePro indicated for?
Sumavel DosePro was approved in 2009 for the acute treatment of migraine, with or without aura, and the acute treatment of cluster headache.
Sumavel DosePro was unique as it was a needle-free delivery system and delivered the medication in a manner similar to a subcutaneous injection.
What other options are available to replace Sumavel DosePro?
The main ingredient of Sumavel DosePro is sumatriptan, which is an active ingredient in several other available medications:
- Sumatriptan tablets (Brand name: Imitrex)
- Sumatriptan nasal spray
- Sumatriptan subcutaneous injection
We've sent a link to download the GoodRx mobile app to your phone.
We were unable to send a link to your phone.